SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2024-03-27 12:49
Tx date 2024-03-22
$GENX
Genix Pharmaceuticals Corporation
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-30,225
-403,000 vol
$0.075 each
1,037,000
Filed 2023-12-28 14:18
Tx date 2023-12-27
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$740.00
+37,000 vol
$0.02 each
10,501,110
Filed 2023-12-20 12:31
Tx date 2023-12-18
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$5,250
+150,000 vol
$0.035 each
10,464,110
Filed 2023-07-02 16:49
Tx date 2023-06-28
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$605.00
+11,000 vol
$0.055 each
10,244,110
Filed 2023-07-02 16:47
Tx date 2023-06-28
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,780
+70,000 vol
$0.054 each
10,314,110
Filed 2023-06-29 19:05
Tx date 2023-06-28
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,355
+61,000 vol
$0.055 each
Filed 2023-06-29 19:04
Tx date 2023-06-28
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,000
+20,000 vol
$0.05 each
Filed 2023-06-29 19:05
Tx date 2023-06-28
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,355
+61,000 vol
$0.055 each
10,314,110
Filed 2023-06-29 19:04
Tx date 2023-06-28
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,000
+20,000 vol
$0.05 each
10,253,110
Filed 2023-06-21 21:29
Tx date 2021-03-22
$GENX
Genix Pharmaceuticals Corporation
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$6,000
+50,000 vol
$0.12 each
350,000
Filed 2023-06-21 21:29
Tx date 2020-08-10
$GENX
Genix Pharmaceuticals Corporation
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$36,000
+300,000 vol
$0.12 each
300,000
Filed 2023-06-21 21:27
Tx date 2020-08-06
$GENX
Genix Pharmaceuticals Corporation
Bottomley, Kevin
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$36,000
+300,000 vol
$0.12 each
300,000
Filed 2023-06-21 21:27
Tx date 2021-03-22
$GENX
Genix Pharmaceuticals Corporation
Bottomley, Kevin
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$6,000
+50,000 vol
$0.12 each
350,000
Filed 2023-06-21 21:25
Tx date 2021-03-22
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$120,000
+1,000,000 vol
$0.12 each
1,000,000
Filed 2021-03-23 19:26
Tx date 2021-03-22
$GENX
Genix Pharmaceuticals Corporation
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$15,000
+50,000 vol
$0.30 each
Filed 2021-03-23 11:03
Tx date 2021-03-22
$GENX
Genix Pharmaceuticals Corporation
Bottomley, Kevin
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$15,000
+50,000 vol
$0.30 each
Filed 2021-03-23 11:01
Tx date 2021-03-22
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$300,000
+1,000,000 vol
$0.30 each
Filed 2020-08-13 18:13
Tx date 2020-08-06
$GENX
Genix Pharmaceuticals Corporation
Bottomley, Kevin
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$90,000
+300,000 vol
$0.30 each
Filed 2020-08-12 14:35
Tx date 2020-08-10
$GENX
Genix Pharmaceuticals Corporation
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$90,000
+300,000 vol
$0.30 each
Filed 2022-10-03 15:15
Tx date 2022-09-30
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$80.00
+1,000 vol
$0.08 each
10,233,110
Filed 2022-09-28 10:31
Tx date 2022-09-27
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$720.00
+9,000 vol
$0.08 each
10,232,110
Filed 2022-08-30 22:15
Tx date 2022-08-29
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$330.00
+3,000 vol
$0.11 each
10,223,110
Filed 2022-08-25 22:25
Tx date 2022-08-24
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$110.00
+1,000 vol
$0.11 each
10,220,110
Filed 2022-04-08 11:45
Tx date 2021-05-19
$GENX
Genix Pharmaceuticals Corporation
Mahmoud, Aziz
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
6,419,671
Filed 2022-04-08 11:35
Tx date 2021-05-19
$GENX
Genix Pharmaceuticals Corporation
Mahmoud, Aziz
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2022-04-08 11:34
Tx date 2021-05-19
$GENX
Genix Pharmaceuticals Corporation
Mahmoud, Aziz
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
1,400,000
Filed 2022-01-27 17:26
Tx date 2021-04-28
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$6,300
+30,000 vol
$0.21 each
9,631,110
Filed 2021-04-29 16:48
Tx date 2021-04-28
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$10,500
+50,000 vol
$0.21 each
Filed 2022-01-18 12:10
Tx date 2022-01-17
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$12,500
+100,000 vol
$0.125 each
10,239,110
Filed 2021-12-24 18:08
Tx date 2021-12-24
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,570
+34,000 vol
$0.105 each
10,139,110
Filed 2021-12-23 16:10
Tx date 2021-12-22
$GENX
Genix Pharmaceuticals Corporation
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-9,742.81
-88,571 vol
$0.11 each
1,440,000
Filed 2021-12-21 19:30
Tx date 2021-12-03
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,800
+20,000 vol
$0.14 each
10,105,110
Filed 2021-12-21 19:30
Tx date 2021-12-03
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,990
+23,000 vol
$0.13 each
10,085,110
Filed 2021-11-12 11:49
Tx date 2021-11-11
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,300
+20,000 vol
$0.165 each
10,062,110
Filed 2021-11-04 14:09
Tx date 2021-11-02
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,400
+16,000 vol
$0.15 each
10,042,110
Filed 2021-10-18 13:58
Tx date 2021-10-15
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$85.00
+500 vol
$0.17 each
10,026,110
Filed 2021-10-13 16:28
Tx date 2021-10-13
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,165
+24,500 vol
$0.17 each
10,025,610
Filed 2021-09-24 16:10
Tx date 2021-09-24
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,150
+17,500 vol
$0.18 each
10,001,110
Filed 2021-09-24 16:08
Tx date 2021-09-24
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,187
+12,500 vol
$0.175 each
9,983,610
Filed 2021-09-10 20:02
Tx date 2021-09-08
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$7,200
+40,000 vol
$0.18 each
9,971,110
Filed 2021-09-01 15:32
Tx date 2021-08-31
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,800
+20,000 vol
$0.19 each
9,931,110
Filed 2021-08-27 11:13
Tx date 2021-08-26
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,000
+10,000 vol
$0.20 each
9,911,110
Filed 2021-08-18 17:03
Tx date 2021-08-18
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$7,920
+44,000 vol
$0.18 each
9,901,110
Filed 2021-08-18 12:07
Tx date 2021-08-17
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,780
+21,000 vol
$0.18 each
9,857,110
Filed 2021-08-12 12:11
Tx date 2021-08-10
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,535
+13,000 vol
$0.195 each
9,836,110
Filed 2021-08-12 12:10
Tx date 2021-08-10
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,400
+22,000 vol
$0.20 each
9,823,110
Filed 2021-08-09 15:44
Tx date 2021-08-06
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$5,700
+30,000 vol
$0.19 each
9,801,110
Filed 2021-08-09 15:43
Tx date 2021-08-05
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,710
+9,000 vol
$0.19 each
9,771,110
Filed 2021-07-30 11:37
Tx date 2021-07-29
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$190.00
+1,000 vol
$0.19 each
9,762,110
Filed 2021-07-30 11:32
Tx date 2021-07-29
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$600.00
+3,000 vol
$0.20 each
9,761,110
Filed 2021-07-29 11:57
Tx date 2021-07-28
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,400
+7,000 vol
$0.20 each
9,758,110
Filed 2021-06-25 18:01
Tx date 2021-06-25
$GENX
Genix Pharmaceuticals Corporation
Lewin, Jamie A.
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-30,000
-150,000 vol
$0.20 each
0
Filed 2021-05-21 11:29
Tx date 2021-05-20
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$5,250
+25,000 vol
$0.21 each
9,751,110
Filed 2021-05-17 12:42
Tx date 2021-05-17
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$15,750
+75,000 vol
$0.21 each
9,726,110
Filed 2021-04-29 16:48
Tx date 2021-04-28
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$10,500
+50,000 vol
$0.21 each
9,651,110
Filed 2021-04-12 10:38
Tx date 2018-08-27
$GENX
Genix Pharmaceuticals Corporation
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-08-12 14:16
Tx date 2018-08-27
$GENX
Genix Pharmaceuticals Corporation
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-03-25 12:35
Tx date 2021-03-22
$GENX
Genix Pharmaceuticals Corporation
Lee, Danny Wayne Kent
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$90,000
+300,000 vol
$0.30 each
700,000
Filed 2021-03-23 19:26
Tx date 2021-03-22
$GENX
Genix Pharmaceuticals Corporation
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$15,000
+50,000 vol
$0.30 each
1,878,571
Filed 2021-03-23 11:03
Tx date 2021-03-22
$GENX
Genix Pharmaceuticals Corporation
Bottomley, Kevin
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$15,000
+50,000 vol
$0.30 each
350,000
Filed 2021-03-23 11:01
Tx date 2021-03-22
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$300,000
+1,000,000 vol
$0.30 each
1,000,000
Filed 2021-03-23 11:00
Tx date 2020-12-30
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-03-22 13:09
Tx date 2021-03-22
$GENX
Genix Pharmaceuticals Corporation
Yea, Darryl
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$240,000
+800,000 vol
$0.30 each
1,100,000
Filed 2021-02-04 13:34
Tx date 2021-01-29
$GENX
Genix Pharmaceuticals Corporation
Lewin, Jamie A.
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services
$36,000
+150,000 vol
$0.24 each
150,000
Filed 2021-02-04 13:29
Tx date 2019-03-11
$GENX
Genix Pharmaceuticals Corporation
Lewin, Jamie A.
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-31 16:40
Tx date 2020-12-30
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$340,086
+6,801,737 vol
$0.05 each
9,601,110
Filed 2020-12-31 16:38
Tx date 2020-12-30
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
2,799,373
Filed 2020-12-23 17:43
Tx date 2020-12-14
$GENX
Genix Pharmaceuticals Corporation
Lee, Danny Wayne Kent
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$88,000
+400,000 vol
$0.22 each
400,000
Filed 2020-12-23 17:41
Tx date 2020-12-14
$GENX
Genix Pharmaceuticals Corporation
Lee, Danny Wayne Kent
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-09-21 19:39
Tx date 2020-09-18
$GENX
Genix Pharmaceuticals Corporation
Yea, Darryl
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$90,000
+300,000 vol
$0.30 each
300,000
Filed 2020-09-21 19:36
Tx date 2020-09-18
$GENX
Genix Pharmaceuticals Corporation
Yea, Darryl
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-09-21 19:32
Tx date 2020-09-18
$GENX
Genix Pharmaceuticals Corporation
Yea, Darryl
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-09-21 19:29
Tx date 2020-09-18
$GENX
Genix Pharmaceuticals Corporation
Yea, Darryl
4 - Director of Issuer
Holder: Investco Capital Management (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
500,000
Filed 2020-08-13 18:13
Tx date 2020-08-06
$GENX
Genix Pharmaceuticals Corporation
Bottomley, Kevin
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$90,000
+300,000 vol
$0.30 each
300,000
Filed 2020-08-13 18:11
Tx date 2019-08-01
$GENX
Genix Pharmaceuticals Corporation
Bottomley, Kevin
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-08-13 14:16
Tx date 2020-07-03
$GENX
Genix Pharmaceuticals Corporation
Lewin, Jamie A.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+450,000 vol
450,000
Filed 2020-08-13 14:12
Tx date 2019-03-11
$GENX
Genix Pharmaceuticals Corporation
Lewin, Jamie A.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-08-12 14:35
Tx date 2020-08-10
$GENX
Genix Pharmaceuticals Corporation
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$90,000
+300,000 vol
$0.30 each
1,828,571
Filed 2020-08-12 14:16
Tx date 2018-08-27
$GENX
Genix Pharmaceuticals Corporation
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
1,528,571
Filed 2020-07-23 12:32
Tx date 2020-07-21
$GENX
Genix Pharmaceuticals Corporation
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$21,000
+100,000 vol
$0.21 each
1,528,571
Filed 2020-07-23 12:32
Tx date 2020-07-21
$GENX
Genix Pharmaceuticals Corporation
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$-210,000
-1,000,000 vol
$0.21 each
1,428,571
Filed 2020-07-23 12:29
Tx date 2020-07-21
$GENX
Genix Pharmaceuticals Corporation
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$210,000
+1,000,000 vol
$0.21 each
2,428,571
Filed 2020-07-23 12:27
Tx date 2018-08-27
$GENX
Genix Pharmaceuticals Corporation
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
1,428,571
Filed 2020-01-22 17:20
Tx date 2020-01-22
$GENX
Genix Pharmaceucticals Corporation
Bottomley, Kevin
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$400.00
+5,000 vol
$0.08 each
5,000
Filed 2020-01-22 17:20
Tx date 2019-08-01
$GENX
Genix Pharmaceucticals Corporation
Bottomley, Kevin
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report